Filter Results

Clinical Studies

Open

  • Clonal Hematopoiesis (CH) And Hematological Toxicity After Cancer Treatment Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn.

    The overall objective of this project is to combine robust clinical data (e.g. prior chemotherapy or radiation exposure, cumulative radiotheranostic dose) with geneticclonal abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in radiotheranostic treated solid tumor patients.
.